Friday 20 October 2017

Showcasing the North East’s excellence in science in London

Newcastle University recently hosted an event in London to showcase Newcastle’s world-class, clinical and academic expertise.

On Thursday 12th October, Professor David Burn, Pro-Vice Chancellor of the Faculty of Medical Sciences, hosted an event at the Newcastle University London campus to showcase Newcastle University’s world class clinical and academic expertise at an event designed to enhance our links with industry and other national partners.

The afternoon/early evening event, held in conjunction with our key strategic partner, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, and supported by the University’s MRC Proximity to Discovery award, attracted 60 external guests including policy makers, funders, pharma and industry representatives and investors.

There were keynotes from the Faculty’s Pro-Vice-Chancellor, Professor David Burn, and the Director of the NIHR Newcastle Biomedical Research Centre, Professor Avan Sayer; as well parallel sessions.

Attendees were given the opportunity to select the parallel session that most closely aligned with their interest in the University and our expertise, and chose from:

  • Diagnostics (chaired by Newcastle NODE Molecular Pathology Director Professor Nick Reynolds and Diagnostic Evidence Co-operative (DEC) Newcastle Director Professor John Simpson)
  • Clinical Trials and Research and Development (Chaired by Newcastle NIHR/Wellcome Trust Clinical Research Facility Director Mark Walker)
  • An investment forum featuring pre-commercial and spin-out companies, (chaired by Head of Enterprise Services in the Faculty of Medical Sciences (FMS), Martin Cox)

The event was a huge success and we are now actively following up a number of collaborative opportunities and investment proposals.

Industry collaboration with the NIHR Newcastle BRC

Professor Avan Sayer delivered the second keynote address, where she introduced the BRC vision of improving lives through world-class research in ageing and long-term conditions. An important remit for the BRC is building collaborative links with the life sciences industry particularly for the newer area of ageing syndromes such as sarcopenia, frailty and multimorbidity.

She commented, “This was a really enjoyable, well attended event and a great opportunity to share the excellence of our translational research in the North East with a much wider audience.

“We have a lot to offer the life sciences industry and there was a great buzz at this dedicated forum. Excitingly, the event has paved the way for a number of new industry collaborations.”